Obstructive sleep apnea and kidney disease: Is there any direct link?

Sleep and Breathing

Volumn 16, Issue 4, 2012, Pages 1009-1016

  Mirrakhimov, Aibek E ^a,b  

^a Kyrgyz State Medical Academy   (Kyrgyzstan)

^b National Centre of Cardiology and Internal medicine named by M Mirrakhimov   (Kyrgyzstan)

Author keywords

Age; Arterial hypertension; Cardiovascular risk; Chronic kidney disease; Dyslipidemia; Gender; Metabolic syndrome; Obesity; Obstructive sleep apnea; Type 2 diabetes mellitus

Indexed keywords

AGING; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; ADULT; AGE; AGED; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; EPIDEMIOLOGY; FEMALE; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; SEX DIFFERENCE; SMOKING; STATISTICS;

ADULT; AGE FACTORS; AGED; CAUSALITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE; SMOKING; STATISTICS AS TOPIC;

EID: 84872311704     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0624-8     Document Type: Review

References (71)

1. Anonymous (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task force. Sleep, 22: 667-689
2. Horner R (2008) Pathophysiology of obstructive sleep apnea. J Cardiopulm Rehabil Prev 28:289-298
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep disordered breathing among middle aged adults. N Engl J Med 328:1230-1235
4. Gonçalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, Branchi T, Moreira LB, Fuchs SC, de Oliveira AC, Fuchs FD (2007) Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 132:1858-1862
5. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G (2009) Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 53:64-69
6. Hung J, Whitford EG, Parsons RW, Hillman DR (1990) Association of sleep apnoea with myocardial infarction in men. Lancet 336:261-264
7. Hedner J, Ejnell H, Caidahl K (1990) Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 8:941-946
8. Hoffstein V, Mateika S (1994) Cardiac arrhythmias, snoring, and sleep apnea. Chest 106:466-471
9. Munoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio R, Aizpuru F, De La Torre G (2006) Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 37:2317-2321
10. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK (2009) Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122:1122-1127
11. Shpirer I, Rapoport MJ, Stav D, Elizur A (2011) Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath. doi: 10.1007/s11325-011-0525-x, PMID: 21559931
12. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131:1387-1392
13. Assoumou HG, Gaspoz JM, Sforza E, Pichot V, Celle S, Maudoux D et al (2011) Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort. Sleep Breath. doi: 10.1007/s11325-011-0593-y, PMID: 21927990
14. Drager LF, Jun J, Polotsky VY (2010) Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17:161-165
15. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047
16. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-S266
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-470
18. O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC (2006) Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17:846-853
19. Swaminathan S, Shah SV (2011) Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int 80:453-463
20. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305
21. U.S. Renal Data System, USRDS (2008) Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
22. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM (2002) Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162:893-900
23. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M (1994) Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 154(19):2219-2224
24. Iseki K, Tohyama K, Matsumoto T, Nakamura H (2008) High prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 31:249-255
25. Davies DF, Shock NW (1950) Age changes in glomerular filtration rate, effective renal plasma flow and tubular excretory capacity in adult males. J Clin Invest 29:496-506
26. Esposito C, Plati A, Mazzullo T, Fasoli G, De Mauri A, Grosjean F, Mangione F, Castoldi F, Serpieri N, Cornacchia F, Dal Canton A (2007) Renal function and functional reserve in healthy elderly individuals. J Nephrol 20:617-625
27. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd (2009) For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 75:1071-1078
28. Poggio ED, Rule AD, Tanchanco R, Arrigain S, Butler RS, Srinivas T, Stephany BR, Meyer KH, Nurko S, Fatica RA, Shoskes DA, Krishnamurthi V, Goldfarb DA, Gill I, Schreiber MJ Jr (2009) Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 75:1079-1087
29. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69:2155-2161
30. US Renal Data System, USRDS (2010) 2010 Annual Data Report: atlas of chronic kidney disease and end- stage renal disease in the United States. National Institutes of Health, National Institute Diabetes and Digestive and Kidney Diseases, Bethesda. Available at http://www.usrds.org
31. Iseki K, Iseki C, Ikemiya Y, Fukiyama K (1996) Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49:800-805
32. Halbesma N, Brantsma AH, Bakker SJ, Jansen DF, Stolk RP, De Zeeuw D, De Jong PE, Gansevoort RT (2008) Gender differences in predictors of the decline of renal function in the general population. Kidney Int 74:505-512
33. Duru OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, Collins A, Klag M, McCullough PA, McGill J, Narva A, Pergola P, Singh A, Norris K (2008) Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 51:192-198
34. Vital signs: current cigarette smoking among adults aged ≥18 years - United States, 2005-2010. On September 6, 2011, this report was posted as an MMWR early release on the MMWR website (http://www.cdc.gov/mmwr). Accessed on 20 Sept 2011
35. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE (2000) Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133:585-591
36. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG (2000) Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 57:2072-2079
37. Orth SR, Schroeder T, Ritz E, Ferrari P (2005) Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20:2414-2419
38. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG (2006) Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 69:2057-2063
39. Warmoth L, Regalado MM, Simoni J, Harrist RB, Wesson DE (2005) Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 330:111-119
40. Lin SJ, Koford JK, Baird BC, Hurdle JF, Krikov S, Habib AN, Goldfarb-Rumyantzev AS (2005) Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation 80:482-486
41. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21-28
42. Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A, Ariza A (2008) Renal injury in the extremely obese patients with normal renal function. Kidney Int 73:947-955
43. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2006) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21:1-6
44. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167-174
45. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134-2140
46. Sun F, Tao Q, Zhan S (2010) Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Nephrology (Carlton) 15:84-92
47. Harsch IA, Schahin SP, Brückner K, Radespiel-Tröger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T, Ficker JH (2004) The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 7:252-259
48. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E (2010) Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 18:507-513
49. Mogensen CE (1999) Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263-285
50. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, Koya D (2005) Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54:2983-2987
51. Kramer HJ, Nguyen QD, Curhan G, Hsu CY (2003) Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289:3273-3277
52. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR (2006) Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55:1832-1839
53. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217-223
54. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E (2005) Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156-161
55. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR (2000) Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 55:736-740
56. Perry HM Jr, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE (1995) Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25:587-594
57. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J (1996) Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18
58. Barbé F, Durán-Cantolla J, Capote F, de la Peña M, Chiner E, Masa JF, Gonzalez M, Marín JM, Garcia-Rio F, de Atauri JD, Terán J, Mayos M, Monasterio C, del Campo F, Gomez S, de la Torre MS, Martinez M, Montserrat JM (2010) Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 181:718-726
59. Phillips CL, Yee BJ, Marshall NS, Liu PY, Sullivan DR, Grunstein RR (2011) Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a, randomized placebo- controlled crossover trial. Am J Respir Crit Care Med 184:355-361
60. Drager L, Polotsky V (2011) Lipid metabolism: a new frontier in sleep apnea research. Am J Respir Crit Care Med 184:288-290
61. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM (2003) Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14:2084-2091
62. Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, Ferris FL 3rd (2004) Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study report no. 26. Kidney Int 66:1173-1179
63. Chaudhary BA, Sklar AH, Chaudhary TK, Kolbeck RC, Speir WA Jr (1988) Sleep apnea, proteinuria, and nephrotic syndrome. Sleep 11:69-74
64. Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S (2007) Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 30:923-929
65. Ahmed SB, Ronksley PE, Hemmelgarn BR, Tsai WH, Manns BJ, Tonelli M, Klarenbach SW, Chin R, Clement FM, Hanly PJ (2011) Nocturnal hypoxia and loss of kidney function. PLoS One 6(4):e19029
66. Chou YT, Lee PH, Yang CT, Lin CL, Veasey S, Chuang LP, Lin SW, Lin YS, Chen NH (2011) Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant 26:2244-2250
67. Szentkiralyi A, Czira ME, Molnar MZ, Kovesdy CP, Remport A, Szeifert L, Vamos EP, Juhasz J, Turanyi CZ, Mucsi I, Novak M (2011) High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: an observational cohort study. Sleep Med 12:267-273
68. Beecroft JM, Pierratos A, Hanly PJ (2009) Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med 5:115-121
69. Markou N, Kanakaki M, Myrianthefs P, Hadjiyanakos D, Vlassopoulos D, Damianos A, Siamopoulos K, Vasiliou M, Konstantopoulos S (2006) Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 184:43-49
70. Unruh ML (2007) Sleep apnea and dialysis therapies: things that go bump in the night? Hemodial Int 11:369-378
71. Kent BD, McNicholas WT (2010) Overview of basic mechanisms of cardiovascular disease in OSA. Eur Respir Mon 50:340-359